Login to Your Account

Biogeneration fund raises €82M for Europe's early stage biopharma

By Nuala Moran
Staff Writer

Tuesday, October 31, 2017

LONDON – Biogeneration Ventures announced the final close of its third early stage fund, far exceeding the initial target of €50 million (US$58.2 million) and going past the revised target of €75 million set in June, to raise €82 million.

That makes Biogeneration Venture Fund III one of the largest focusing on seed investments in European biopharma startups.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription